Earnings per share |
Earnings per share | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30 | | September 30 | (in millions of U.S. dollars, except share and per share data) | 2021 | | 2020 | | 2021 | | 2020 | Numerator: | | | | | | | | Net income | $ | 1,833 | | | $ | 1,194 | | | $ | 6,398 | | | $ | 1,115 | | Denominator: | | | | | | | | Denominator for basic earnings per share: | | | | | | | | Weighted-average shares outstanding | 435,318,088 | | | 451,794,046 | | | 443,595,026 | | | 451,683,093 | | Denominator for diluted earnings per share: | | | | | | | | Share-based compensation plans | 3,123,550 | | | 1,471,434 | | | 3,032,989 | | | 1,894,699 | | Weighted-average shares outstanding and assumed conversions | 438,441,638 | | | 453,265,480 | | | 446,628,015 | | | 453,577,792 | | Basic earnings per share | $ | 4.21 | | | $ | 2.64 | | | $ | 14.42 | | | $ | 2.47 | | Diluted earnings per share | $ | 4.18 | | | $ | 2.63 | | | $ | 14.33 | | | $ | 2.46 | | Potential anti-dilutive share conversions | 1,758,853 | | | 7,053,316 | | | 1,439,882 | | | 6,767,727 | |
Excluded from weighted-average shares outstanding and assumed conversions is the impact of securities that would have been anti-dilutive during the respective periods.
|